PROTEINA logo

PROTEINA

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level

32 employees · est. 2015 · Seoul, Korea South

VS
SomaScan logo

SomaScan

Transforming research and healthcare with industry-leading proteomics

143 employees · est. 2000 · San Diego, United States

SomaScan is the older company (2015 vs 2000); SomaScan is the larger of the two.

Side-by-Side Comparison

PROTEINA SomaScan
Founded
2015 2000 older
Headquarters
Seoul, Korea South San Diego, United States
Employees
32 143 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Medical Devices
Funding Stage
Series C Post Ipo Equity
Total Funding
$19.00B $815.02M
Funding Rounds
2 15
Services
Not tracked yet SomaScan Assay Services, SomaScan Data Consulting Services, SomaSignal Tests, CyTOF cytometry services
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Academic Medical Centers, Contract Research Organizations
Taxonomy
Protein-protein Interaction, PPI Analysis, Single-molecule Co-immunoprecipitation, Quantitative Measurements, Drug Efficacy Modeling, Protein Analysis, Disease Diagnostics, Drug Discovery, Biotech Startup, Molecular Analysis, Diagnostic Technology, Pharmaceutical Research, Biomedical Innovation Proteomics, Protein Biomarker Discovery, Clinical Diagnostics, SOMAmers, SomaScan Platform, Protein Detection, Drug Discovery, Neurology Diagnostics, Oncology Diagnostics, Cardiovascular Disease Diagnostics, Metabolic Disease Diagnostics, Illumina Acquisition, Aptamer Technology, Healthcare Innovation
Website
proteina.co.kr somalogic.com
PROTEINA logo

About PROTEINA

PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform, utilizing proprietary 'single-molecule co-immunoprecipitation' technology for quantitative measureme...

SomaScan logo

About SomaScan

SomaScan, now operating as a part of Illumina, is at the forefront of biotechnology innovation. Founded in 2000 and headquartered in the United States, the company is recognized for its pioneering work in the realm of proteomics, which is crucial in transforming both research and healthcare sectors....

We will tell you when either one moves

BounceWatch watches PROTEINA and SomaScan for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at PROTEINA and SomaScan — by email.

Frequently Asked Questions

PROTEINA — Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level. SomaScan — Transforming research and healthcare with industry-leading proteomics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
PROTEINA has raised $19.00B while SomaScan has raised $815.02M.
PROTEINA and SomaScan operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare PROTEINA with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at PROTEINA on 12 Sep 2024, and SomaScan on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes